MedTrace Logo

Radiomics Multifactorial Biomarker for Pulmonary Nodules

NCT03872362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2019-03-13

No results posted yet for this study

Summary

The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.

Conditions

  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Lung Diseases
  • Neoplasms
  • Pathology

Interventions

DIAGNOSTIC_TEST

radiomics

The high-throughput extraction of large amounts of quantitative image features from medical images

Sponsors & Collaborators

  • Affiliated Zhongshan Hospital of Dalian University

    collaborator OTHER

  • The Second Affiliated Hospital of Dalian Medical University

    collaborator OTHER

  • The Fifth Hospital of Dalian

    collaborator UNKNOWN

  • Maastricht University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-11
Primary Completion
2019-01-11
Completion
2019-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03872362 on ClinicalTrials.gov